(Other OTC:OTCM),(OTC US:OTCM),(Other OTC:FSRL), NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced First Reliance Bancshares, Inc. (OTCQX: FSRL), the holding company for First Reliance Bank, has qualified to trade on the OTCQX(R) Best Market. First Reliance […]
(NasdaqGM:ACIU), AC Immune Reports Third Quarter 2025 Financial Results and Provides a Corporate Update Sharpened investment focus on high-value assets, including three Phase 2 active immunotherapy programs and small molecule programs targeting NLRP3, Tau and a-syn Cash resources of CHF 108.5 million as of September 30, 2025, provide funding to the end of Q3 2027
New information to be presented on the study design and methodology of Purespring's Phase I/II trial of PS-002, an AAV-based therapy delivering the complement factor I to podocytes in patients with IgA nephropathy Patient and carer feedback from insights sessions on gene therapy study concepts in nephrology will be presented Purespring co-author paper with real
(NasdaqGM:EDAP), EDAP to Present at Jefferies Global Healthcare Conference in London Company to Present and Host 1×1 Investor Meetings on Tuesday, November 18th, 2025 AUSTIN, Texas, November 4, 2025 — EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled to
(NASDAQ:NSPR), MIAMI, Nov. 04, 2025 (GLOBE NEWSWIRE) — InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard(R) Prime carotid stent system for the prevention of stroke, today announced financial and operating results for the third quarter and nine months ended September 30, 2025. Recent Business Highlights: Initiated U.S. commercial launch of the
— Novavax has successfully achieved U.S. BLA approval and completed both EU and U.S. marketing authorization transfers for Nuvaxovid™ to Sanofi in line with its CLA and its corporate strategy, securing a total of $225 million in non-dilutive capital year-to-date 2025 Novavax, Inc. (Nasdaq: NVAX) has completed the transfer of the U.S. marketing authorization for
N2K Networks today announced the launch of the Data Security Decoded podcast on the N2K CyberWire network. Sponsored by Rubrik (NYSE: RBRK), the show offers vendor-agnostic, research-driven insights that help cybersecurity and IT professionals reduce data security risk and improve resilience outcomes. Data Security Decoded provides actionable insights for practitioners who want to prepare for
Gas. Hybrid. Electric. Hydrogen. Toyota Showcases a Multi-Pathway Future of Mobility and Adventure. Toyota arrives at the 2025 Specialty Equipment Market Association (SEMA) Show with an inspiring message:”Powered by Possibility.”As the industry explores a future shaped by an ever-evolving variety of powertrain technologies, Toyota demonstrates how its diverse lineup-gasoline, hybrid, plug-in hybrid, battery-electric, and hydrogen
RADCOM Ltd. (NASDAQ: RDCM)announced today that it has signed a multi-year agreement with 1GLOBAL to deploy RADCOM ACE, its cutting-edge assurance solution designed to optimize network operations and deliver next-generation, AI-powered assurance. 1GLOBAL is a technology-driven global mobile communications provider that delivers seamless compliance and connectivity solutions to leading global financial institutions, multinational enterprises, mobile
CIMG Inc. (“CIMG” or the “Company”) (Nasdaq: IMG), a business group specializing in digital health and sales development, which utilizes technology and marketing to enhance its business partners' sales growth and commercial value, today announced that the Company has entered into a tripartite agreement with FlowStocks and DYT INFO PTE. LTD. (“DYT”), a shareholder of